Pulmonary Embolism Response Team : Inpatient Structure, Outpatient Follow-up, and Is It the Current Standard of Care? - 18/08/18

Doi : 10.1016/j.ccm.2018.04.019

Rachel Rosovsky, MD, MPH ^a,^⁎ , Jorge Borges, MD ^b, Christopher Kabrhel, MD, MPH ^c, Kenneth Rosenfield, MD ^b
^a Division of Hematology and Oncology, Department of Medicine, Massachusetts Hospital, 55 Fruit Street, Boston, MA 02114, USA
^b Division of Cardiology, Section of Vascular Medicine and Intervention, Department of Medicine, Massachusetts Hospital, 55 Fruit Street, Boston, MA 02114, USA
^c Department of Emergency Medicine, Center for Vascular Emergencies, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA

^∗Corresponding author.

Résumé

Pulmonary Embolism Response Teams (PERTs) are being created around the United States to immediately and simultaneously bring together multiple specialists to determine the best course of action and coordinate clinical care for patients with severe pulmonary embolism (PE). The organization and structure of each PERT will depend on local clinical demands and resources. Creating a follow up clinic for PE patients after discharge from the hospital is an essential component of any PERT program. PERT programs, which have come together to form the PERT Consortium®, are changing the landscape of PE treatment and may represent a new standard of care.

Le texte complet de cet article est disponible en PDF.

Keywords : Pulmonary embolism (PE), Pulmonary embolism response team (PERT), Multidisciplinary care, Follow-up clinic, Anticoagulation management, Direct oral anticoagulants (DOACs)

Plan

Key points

Introduction

Case presentation

Purpose of pulmonary embolism response team

Inpatient structure of pulmonary embolism response team

Continuation of case presentation

Outpatient follow-up clinic

Occult Malignancy Screening

Thrombophilia Testing

Anticoagulation Management

Chronic Thromboembolic Pulmonary Hypertension Evaluation

Inferior Vena Cava Filter Retrieval

Summary

Is pulmonary embolism response team the new standard of care?

Disclosures: R. Rosovsky discloses the following relationships: research support from Janssen Pharmaceuticals and Bristol Meyer Squibb; consultant to Bayer. J. Borges has no disclosures. C. Kabrhel discloses the following relationships: consultant to Diagnostica Stago, Janssen Pharmaceuticals, Siemens, Pfizer, and Portola Pharmaceuticals; grant recipient from Diagnostica Stago, Siemens Healthcare, Janssen Pharmaceuticals, and Boehringer Ingelheim. K. Rosenfield discloses the following relationships: consultant to Cardinal Health and SurModics; grants/contracts with Abbott Vascular, Atrium, Lutonix/BARD, and The Medicines Company; equity with Access Closure, Inc and AngioDynamics/Vortex; personal compensation from Cook, HCRI, and The Medicines Company; board member with VIVA Physicians.

Export

Vol 39 - N° 3

P. 621-630 - septembre 2018 Retour au numéro

Article précédent

Chronic Thromboembolic Pulmonary Hypertension : An Update
Jean M. Elwing, Anjali Vaidya, William R. Auger

| Article suivant

Endovascular and Open Surgery for Deep Vein Thrombosis
Cassius Iyad Ochoa Chaar, Afsha Aurshina

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Pulmonary Embolism Response Team : Inpatient Structure, Outpatient Follow-up, and Is It the Current Standard of Care? - 18/08/18

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL